联环药业预计2025年归属净利润为负值

Core Viewpoint - Lianhuan Pharmaceutical (600513) announced that it expects a negative net profit attributable to shareholders for the fiscal year 2025, indicating an anticipated operating loss for that year [1] Financial Performance - The company is in the process of accelerating its financial accounting work to comply with the regulations of the Shanghai Stock Exchange [1] - A formal earnings forecast for 2025 will be disclosed as soon as possible, with the final financial data to be confirmed in the official 2025 annual report [1]